LAROTRECTINIB | LAROTRECTINIB | ATC L01XE53
ANTINEOPLASTIC KINASE INHIBITOR TREATMENT OF SOLID TUMOR INHIBITOR OF THE TROPOMYOSIN RECEPTOR KINASES (TRK), TRKA, TRKB, AND TRKC | ORAL | Cmax 1.84 MICROMOLAR Tmax 1 HOUR F 34 PERCENT VD 48 LITER PPB 70 PERCENT Cl 98 LITER / HOUR HT 2.9 HOUR SOLUBILITY FREELY SOLUBLE IN WATER AT PH 6.8 | TROPOMYOSIN RECEPTOR KINASE | High affinity nerve growth factor receptor P04629 | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |